ARCHIVED: NOT AVAILABLE FOR CREDIT
Common Inflammatory Diseases of the Liver: Hepatitis B, Hepatitis C, and Nonalcoholic Fatty Liver Disease

 

In this lecture, Dr. Gallegos-Orozco will provide an epidemiologic overview of chronic viral hepatitis B and C and discuss the diagnostic approach and goals of antiviral therapy, as well as the current treatment criteria used to select therapy.

Originally published on June 9, 2022

Lecture Presenter

Juan F. Gallegos-Orozco, MD

Juan F. Gallegos-Orozco, MD

Assistant Professor (Clinical) of Internal Medicine
University of Utah School of Medicine

Dr. Juan F. Gallegos-Orozco graduated from medical school in Mexico and completed postgraduate medical education in internal medicine and gastroenterology in both Mexico and the United States, where he recently completed fellowship training in Transplant Hepatology at the prestigious Mayo School of Graduate Medical Education, Mayo Clinic, in Phoenix, Arizona. His main clinical and research interests include the management of chronic viral hepatitis, nonalcoholic liver disease, and liver transplantation. He has published many research articles on these and other topics and has authored several book chapters pertaining to liver diseases. Dr. Gallegos-Orozco recently joined the Division of Gastroenterology, Hepatology, and Nutrition at the University of Utah School of Medicine as an Assistant Professor of Medicine.

Objectives

After this presentation, participants will be able to:

  • Review the global and national epidemiology of chronic hepatitis B, hepatitis C, and nonalcoholic fatty liver disease (NAFLD)
  • Describe the diagnostic approach to patients with hepatitis B, hepatitis C, and NAFLD
  • Discuss current treatment options and criteria used to select therapy in patients with chronic hepatitis B or chronic hepatitis C
  • Compare and contrast the differences between simple steatosis and nonalcoholic steatohepatitis (NASH)
  • Review the key pathogenesis in NAFLD/NASH
  • Describe the current and future management of NAFLD/NASH

Sponsored by:

University of Utah School of Medicine, Department of Pathology, and ARUP Laboratories